Furthermore, Mynaric today announced that it received a notification letter dated January 13, 2025 (the "Deficiency Letter II") from Nasdaq notifying that Mynaric is no longer in compliance with ...

today announced that it received the anticipated Nasdaq deficiency letter issued to companies whose stock's closing bid price remains below $1.00 for 30 consecutive business days. SOBRsafe has ...

In accordance with Nasdaq’s listing rules, the Company has 60 calendar days after the Deficiency Letter to submit a plan to regain compliance with the Listing Rule. Following receipt of such ...

Under the Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company has until July 2, 2025 (that is, 60 calendar days from the date of the Deficiency Letter) to submit to Nasdaq a plan (the "Compliance ...

The Deficiency Letter has no immediate effect on the listing of Mynaric's ADS, which continue to trade under the symbol "MYNA." The Deficiency Letter provided that, in accordance with Nasdaq ...

Under the Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company has until July 2, 2025 (that is, 60 calendar days from the date of the Deficiency Letter) to submit to Nasdaq a plan (the "Compliance Plan") ...